Issue highlights--November 2014.
Issue highlights--November 2014.
复制标题
问题要点——2014 年 11 月。
DOI:
10.1002/cyto.b.21186
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
McCoyJr,JPhilip
中科院分区:
文献类型:
--
作者:
McCoyJr,JPhilip
This issue of Cytometry Part B: Clinical Cytometry contains a number of exciting articles on a wide variety of topics. Included among these is an article by Peijers and colleagues concerning the harmonization of immunophenotyping. Both harmonization and standardization of immunophenotyping are topics of keen interest to cytometrists. Whereas standardization requires strict adherence to an accepted practice or marker set, harmonization permits more flexibility while still achieving highly consistent results. Standardization of various clinical assays has been the topic of several key manuscripts in this journal over the past several years (1–3). For example, efforts towards the standardization of detection of clones in paroxysmal nocturnal hemoglobinuria (PNH) have been presented by Sutherland and colleagues (1) as well as by Fletcher and coworkers (2). In recent years harmonization inflow cytometry has been the subject of high visibility papers such as those by Maecker and colleagues (4, 5) as it has been increasingly recognized that there needs to be a high degree of consistency among laboratories while still permitting a certain amount of flexibility in the performance of assays by individual laboratories. In this issue, Preijers and coworkers (6) compare the use of alternative antibody clones and cytometers to those used in the original standardized protocol (7). By demonstrating a high degree of comparability between the standard reagents and their own, Preijers et al have made this protocol more ‘agnostic’about the use of a particular brand of reagents or instrument, and thus harmonizing data collection among a potentially wider group of laboratories.Also in this issue, Krishnan and coworkers take a close look at analytical variables such as anticoagulants, age, and gender in the measurement of cytokines and chemokines from the peripheral circulation of healthy donors (8). Increasingly, these variables are being recognized as significantly impacting data from both multiplex bead cytokine assays (9) as well as immunophenotyping (10). In the current study Krishnan and colleagues show profound anti-coagulant and age-dependent differences in the measurement of various cytokines and chemokines using a 23-plex bead array assay. A key ‘take home’message from this paper is the proper design and implementation of clinical protocols for cytokine measurements. The clinic must take care to collect all specimens in only the one anticoagulant specified in the protocol and never substitute serum for plasma, or vice versa. Doing so could lead to artifacts within the data and lead to spurious conclusions in the study. The agerelated differences observed in the levels of several cytokines indicate the need to carefully match the ages of any control cohort to the subjects of the study.
登录
查看更多内容
影响因子:
4.3
作者:
G. Flannery;R. Robins;R. W. Baldwin
通讯作者:
R. W. Baldwin
影响因子:
6.4
作者:
R. Kiessling;G. Petrányi;G. Klein;H. Wigzell
通讯作者:
H. Wigzell
影响因子:
5.2
作者:
R. Bast;B. Bast;H. Rapp
通讯作者:
H. Rapp
DOI:
10.1093/jnci/46.4.831
发表时间:
1971
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
B. Zbar;I. Bernstein;H. Rapp
通讯作者:
H. Rapp
影响因子:
6.6
作者:
A. Pang;A. Morales
通讯作者:
A. Morales